Effects of Ianalumab Treatment on B-Cell Activation, Maturation, and Maintenance of Vaccine Titers in Patients With Primary Immune Thrombocytopenia in the Phase 2 VAYHIT3 Study

ianalumab (VAY736) - Novartis

https://www.sciencedirect.com/science/article/abs/pii/S2152265026022317

Thomas Stauch 1; Charlotte Bradbury 2; Tomás José González-López 3; Guillaume Moulis 4; Nichola Cooper 5; Karolin Trautmann 6; Patrick Urban 7; Renxin Lin 8; Tiffany Loy 7; Dilini Kothalawala 9; Kevin Vervier 7; Fabienne Le Gac 7; David Kuter 10

Sep 1, 2026